These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 26090667)

  • 1. Trypanosoma cruzi Infection through the Oral Route Promotes a Severe Infection in Mice: New Disease Form from an Old Infection?
    Barreto-de-Albuquerque J; Silva-dos-Santos D; Pérez AR; Berbert LR; de Santana-van-Vliet E; Farias-de-Oliveira DA; Moreira OC; Roggero E; de Carvalho-Pinto CE; Jurberg J; Cotta-de-Almeida V; Bottasso O; Savino W; de Meis J
    PLoS Negl Trop Dis; 2015 Jun; 9(6):e0003849. PubMed ID: 26090667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Versus Intragastric Inoculation: Similar Pathways of
    Barreto de Albuquerque J; Silva Dos Santos D; Stein JV; de Meis J
    Front Immunol; 2018; 9():1734. PubMed ID: 30100907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dogs infected with the blood trypomastigote form of Trypanosoma cruzi display an increase expression of cytokines and chemokines plus an intense cardiac parasitism during acute infection.
    de Souza SM; Vieira PM; Roatt BM; Reis LE; da Silva Fonseca K; Nogueira NC; Reis AB; Tafuri WL; Carneiro CM
    Mol Immunol; 2014 Mar; 58(1):92-7. PubMed ID: 24317279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coinfection with different Trypanosoma cruzi strains interferes with the host immune response to infection.
    Rodrigues CM; Valadares HM; Francisco AF; Arantes JM; Campos CF; Teixeira-Carvalho A; Martins-Filho OA; Araujo MS; Arantes RM; Chiari E; Franco GR; Machado CR; Pena SD; Faria AM; Macedo AM
    PLoS Negl Trop Dis; 2010 Oct; 4(10):e846. PubMed ID: 20967289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of infection in mice inoculated by the oral route with different developmental forms of Trypanosoma cruzi I and II.
    Dias GB; Gruendling AP; Araújo SM; Gomes ML; Toledo MJ
    Exp Parasitol; 2013 Nov; 135(3):511-7. PubMed ID: 23994765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential susceptibility to acute Trypanosoma cruzi infection in BALB/c and C57BL/6 mice is not associated with a distinct parasite load but cytokine abnormalities.
    Roggero E; Perez A; Tamae-Kakazu M; Piazzon I; Nepomnaschy I; Wietzerbin J; Serra E; Revelli S; Bottasso O
    Clin Exp Immunol; 2002 Jun; 128(3):421-8. PubMed ID: 12067296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral Route Driven Acute
    Antunes D; Marins-Dos-Santos A; Ramos MT; Mascarenhas BAS; Moreira CJC; Farias-de-Oliveira DA; Savino W; Monteiro RQ; de Meis J
    Front Immunol; 2019; 10():1073. PubMed ID: 31139194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [TH1 response in the experimental infection with Trypanosoma cruzi].
    Cardoni RL; Antúnez MI; Abrami AA
    Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unraveling Chagas disease transmission through the oral route: Gateways to Trypanosoma cruzi infection and target tissues.
    Silva-Dos-Santos D; Barreto-de-Albuquerque J; Guerra B; Moreira OC; Berbert LR; Ramos MT; Mascarenhas BAS; Britto C; Morrot A; Serra Villa-Verde DM; Garzoni LR; Savino W; Cotta-de-Almeida V; de Meis J
    PLoS Negl Trop Dis; 2017 Apr; 11(4):e0005507. PubMed ID: 28379959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-17 is necessary for host protection against acute-phase Trypanosoma cruzi infection.
    Miyazaki Y; Hamano S; Wang S; Shimanoe Y; Iwakura Y; Yoshida H
    J Immunol; 2010 Jul; 185(2):1150-7. PubMed ID: 20562260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of IFN-γ coding plasmid supplementation in the immune response and protection elicited by Trypanosoma cruzi attenuated parasites.
    Pérez Brandán C; Mesías AC; Parodi C; Cimino RO; Pérez Brandán C; Diosque P; Basombrío MÁ
    BMC Infect Dis; 2017 Nov; 17(1):732. PubMed ID: 29178839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The entrance route: Oral, mucous, cutaneous, or systemic has a marked influence on the outcome of Trypanosoma cruzi experimental infection.
    Gonçalves KR; Mazzeti AL; Nascimento AFDS; Castro-Lacerda In Memory JM; Nogueira-Paiva NC; Mathias FAS; Reis AB; Caldas S; Bahia MT
    Acta Trop; 2022 Oct; 234():106581. PubMed ID: 35779591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathological changes in the gastrointestinal tract and systemic alterations triggered by experimental oral infection with Trypanosoma cruzi.
    Carvalho LM; de Carvalho TV; Ferraz AT; Marques FS; Roatt BM; Fonseca KDS; Reis LES; Carneiro CM; Vieira PMA
    Exp Parasitol; 2020 Nov; 218():108012. PubMed ID: 33011239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interference of natural mouse hepatitis virus infection with cytokine production and susceptibility to Trypanosoma cruzi.
    Torrecilhas AC; Faquim-Mauro E; Da Silva AV; Abrahamsohn IA
    Immunology; 1999 Mar; 96(3):381-8. PubMed ID: 10233719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trypanosoma cruzi: IL-10, TNF, IFN-gamma, and IL-12 regulate innate and acquired immunity to infection.
    Abrahamsohn IA; Coffman RL
    Exp Parasitol; 1996 Nov; 84(2):231-44. PubMed ID: 8932773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splenectomy increases mortality in murine Trypanosoma cruzi infection.
    Maioli TU; Assis FA; Vieira PM; Borelli P; Santiago H; Alves R; Romanha AJ; Carneiro CM; Faria AM
    Scand J Immunol; 2011 Jan; 73(1):36-45. PubMed ID: 21129001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin treatment exacerbates oral infections by Trypanosoma cruzi.
    Cossentini LA; Da Silva RV; Yamada-Ogatta SF; Yamauchi LM; De Almeida Araújo EJ; Pinge-Filho P
    Exp Parasitol; 2016 May; 164():64-70. PubMed ID: 26826555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin Enhances the Anti-Trypanosoma cruzi Activity of Benznidazole-Based Chemotherapy in Acute Experimental Chagas Disease.
    Novaes RD; Sartini MV; Rodrigues JP; Gonçalves RV; Santos EC; Souza RL; Caldas IS
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3355-64. PubMed ID: 27001816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage migration inhibitory factor contributes to host defense against acute Trypanosoma cruzi infection.
    Reyes JL; Terrazas LI; Espinoza B; Cruz-Robles D; Soto V; Rivera-Montoya I; Gómez-García L; Snider H; Satoskar AR; Rodríguez-Sosa M
    Infect Immun; 2006 Jun; 74(6):3170-9. PubMed ID: 16714544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction with host factors exacerbates Trypanosoma cruzi cell invasion capacity upon oral infection.
    Covarrubias C; Cortez M; Ferreira D; Yoshida N
    Int J Parasitol; 2007 Dec; 37(14):1609-16. PubMed ID: 17640647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.